Home › Free Stock Grades › STXS
Stereotaxis, Inc. (STXS) Stock Grade
STXS · Healthcare
A+
Market Cap
$209.2M
P/E Ratio
—
Revenue Growth (YoY)
+20.3%
Net Margin
-66.9%
Return on Equity
—
Dividend Yield
None
About Stereotaxis, Inc.'s fundamentals
Stereotaxis is a small-cap healthcare company with a $209.2 million market capitalization that reported strong revenue growth of 20.3% year-over-year, indicating expanding demand for its medical equipment and services. However, the company is currently unprofitable, posting a net loss with a negative net margin of -66.9%, meaning it spent significantly more than it earned during its latest fiscal year. The company does not pay a dividend, which is typical for loss-making businesses focused on reinvestment and growth.